METHOD FOR PREDICTING DYSPLASTIC COXARTHROSIS DEVELOPMENT COURSE BY DETERMINING OSTEOTROPIC CALCITONIN HORMONE LEVEL IN BLOOD SERUM

FIELD: medicine. ^ SUBSTANCE: method involves determining content of osteotropic calcitonin hormone of direct action in blood serum. The value being equal to 5 pkg/ml, non-progressing dysplastic coxarthrosis development course is predicted. The value being equal to or greater than 6 pkg/ml, progress...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DUDIN M.G, AVRUNIN A.S, KORNILOV N.V, GUBAJDULIN G.R, KAZEMIRSKIJ V.E, VOJTOVICH A.V, EHPSHTEJN G.G
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine. ^ SUBSTANCE: method involves determining content of osteotropic calcitonin hormone of direct action in blood serum. The value being equal to 5 pkg/ml, non-progressing dysplastic coxarthrosis development course is predicted. The value being equal to or greater than 6 pkg/ml, progressive disease development course is predicted. ^ EFFECT: enhanced accuracy of prognosis when no reliable X-ray or clinical data are available.